Hexalen (Eisai Inc.)


Welcome to the PulseAid listing for the Hexalen drug offered from Eisai Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Eisai Inc.
NON-PROPRIETARY NAME: altretamine
SUBSTANCE NAME: ALTRETAMINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1990-12-26
END MARKETING DATE: 0000-00-00


Hexalen HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHexalen from Eisai Inc.
LABELER NAME: Eisai Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/1)
START MARKETING DATE: 1990-12-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62856-001_81007003-bba4-467e-b643-08f1101258c9
PRODUCT NDC: 62856-001
APPLICATION NUMBER: NDA019926

Other ALTRETAMINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Eisai Inc.Hexalen